{"axis": 2, "biomarker_name": "p-tau181", "statistic_type": "auc", "value": 0.74, "confidence_interval": [0.69, 0.79], "sample_size": 2277, "cohort_description": "MEMENTO, a large prospective cohort", "primary_disease": "Alzheimer's Disease", "source_snippet": "In a large prospective cohort (MEMENTO, n=2,277), blood phosphorylated tau181 (p-tau181) was the best single blood biomarker for identifying amyloid-PET positivity (AUC = 0.74, 95% CI: 0.69\u20130.79) and predicting 5-year risk of AD/mixed dementia (c-index = 0.73, 95% CI: 0.69\u20130.77)."}
{"axis": 2, "biomarker_name": "p-tau181", "statistic_type": "c-index", "value": 0.83, "confidence_interval": [0.69, 0.97], "sample_size": null, "cohort_description": "patients with a Clinical Dementia Rating (CDR) of 0", "primary_disease": "Alzheimer's Disease", "source_snippet": "The predictive accuracy increased in patients with a Clinical Dementia Rating (CDR) of 0 (c-index = 0.83, 95% CI: 0.69\u20130.97) compared to those with CDR = 0.5 (c-index = 0.70, 95% CI: 0.66\u20130.74)."}
{"axis": 2, "biomarker_name": "Gene expression-based blood biomarker panels", "statistic_type": "auc", "value": 0.886, "confidence_interval": null, "sample_size": null, "cohort_description": "AD", "primary_disease": "Alzheimer's Disease", "source_snippet": "Gene expression-based blood biomarker panels using machine learning achieved ROC-AUCs of 0.886 for AD and 0.743 for PD, supporting their potential for early diagnosis."}
{"axis": 2, "biomarker_name": "NfL", "statistic_type": "auc", "value": 0.743, "confidence_interval": null, "sample_size": null, "cohort_description": "PD", "primary_disease": "Parkinson\u2019s Disease", "source_snippet": "Gene expression-based blood biomarker panels using machine learning achieved ROC-AUCs of 0.886 for AD and 0.743 for PD, supporting their potential for early diagnosis."}
